The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
Abstract Background Pancreatic adenocarcinoma (PAAD) is a common malignancy with a very low survival rate. More and more studies have shown that SPTAN1 may be involved in the development and progression of a variety of tumors, including rectal cancer, Pancreatic adenocarcinoma, etc., and may affect...
Saved in:
Main Authors: | Wei Guo, LingYu Hu, ZhaoFeng Gao, XiaoRong Liu, XiaoDan Yang, XiaoGuang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-024-03581-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2025-02-01) -
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01) -
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
by: XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou
Published: (2024-11-01) -
FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival
by: Nathalie B. Rasko, et al.
Published: (2025-01-01) -
Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
by: Guanxiang Zhuo, et al.
Published: (2025-01-01)